Earnings results for Akumin (NASDAQ:AKU)
Akumin Inc. is estimated to report earnings on 08/16/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date.
Analyst Opinion on Akumin (NASDAQ:AKU)
3 Wall Street analysts have issued ratings and price targets for Akumin in the last 12 months. Their average twelve-month price target is $3.50, predicting that the stock has a possible upside of 19.45%. The high price target for AKU is $3.50 and the low price target for AKU is $3.50. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of “Hold.”
Akumin has received a consensus rating of Hold. The company’s average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings. According to analysts’ consensus price target of $3.50, Akumin has a forecasted upside of 19.5% from its current price of $2.93. Akumin has only been the subject of 2 research reports in the past 90 days.
Dividend Strength: Akumin (NASDAQ:AKU)
Akumin does not currently pay a dividend. Akumin does not have a long track record of dividend growth.
Insiders buying/selling: Akumin (NASDAQ:AKU)
In the past three months, Akumin insiders have not sold or bought any company stock. Only 36.22% of the stock of Akumin is held by institutions.
Earnings and Valuation of Akumin (NASDAQ:AKU
Earnings for Akumin are expected to grow by 233.33% in the coming year, from $0.06 to $0.20 per share. The P/E ratio of Akumin is 293.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.61. The P/E ratio of Akumin is 293.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 41.56.
More latest stories: here